1-4 of 4
James McCloskey, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (cedazuridine/decitabine) Compared to IV Decitabine

Guillermo Garcia-Manero, MD, James McCloskey, MD, Elizabeth A. Griffiths, MD, Karen W.L. Yee, MD, Amer M. Zeidan, MBBS, MHS, Aref Al-Kali, MD, Kim-Hien Dao, DO, PhD, H. Joachim Deeg, MD, Prapti A. Patel, MD, Mitchell Sabloff, MSc,MDFRCPC, Mary-Margaret Keating, MD, Nancy Zhu, MD, Nashat Y. Gabrail, MD, Salman Fazal, MD, Joseph Maly, MD, Olatoyosi Odenike, MD, Aditi Shastri, MD, Amy E. DeZern, MD, Casey L. O'Connell, MD, Gail J. Roboz, MD, Aram Oganesian, PhD, Yong Hao, MD PhD, Harold N. Keer, MD PhD, Mohammad Azab, MD, Michael R. Savona, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 846.
https://doi.org/10.1182/blood-2019-122980
Published: 2019
Journal Articles

Combined Venetoclax and Hypomethylating Agent (HMA) Therapy Induces High Response Rates in Patients with Myelodysplastic Syndrome Including Patients Previously Failing HMA

Brian J Ball, Christopher Famulare, MS, Eytan M. Stein, MD, Martin S. Tallman, MD, Saar I. Gill, MD PhD, Benjamin M Manning, MD PhD, Jamie Koprivnikar, MD, James McCloskey, MD, Rebecca Testi, NP-C, BSN, RN, MSN, OCN, Najla Al Ali, M.Sc, David A Sallman, MD, Eric Padron, MD, Aaron D Goldberg, MD PhD, Rami S. Komrokji, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4241.
https://doi.org/10.1182/blood-2019-125113
Published: 2019
Journal Articles

Blinatumumab Induces Responses in Extramedulary B-Cell Acute Lymphoid Leukemia (B-ALL) and Lymphoid Blast Crisis Chronic Myelogenous Leukemia (CML), and Rarely Results in CD19 Negative Relapse

Jamie Koprivnikar, MD, Danielle Marcotulli, APN, Elizabeth Jones, RN, Grace Perry, APN, Yen-Hong Kuo, PhD, Joelle Gagnon, NP, Maritess Aviador, RN, Genique Stanislaus, ANP, James McCloskey, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2703.
https://doi.org/10.1182/blood-2018-99-120172
Published: 2018
Journal Articles

Interim Data from a Phase 1 Study Evaluating Pyrrolobenzodiazepine-Based Antibody Drug Conjugate ADCT-402 (Loncastuximab Tesirine) Targeting CD19 for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Nitin Jain, MD, Rebecca B. Klisovic, MD, Wendy Stock, MD, David Ungar, MD, Amer M. Zeidan, MD, Ehab Atallah, MD, James McCloskey, MD, Leonard Heffner, MD, Benjamin Tomlinson, MD, Hagop M. Kantarjian, MD, Shui He, PhD, Joseph Boni, PhD, Matthew J. Wieduwilt
Journal: Blood
Blood (2017) 130 (Supplement 1): 1321.
https://doi.org/10.1182/blood.V130.Suppl_1.1321.1321
Published: 2017